Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4

Nature Immunology

Volumn 4, Issue 10, 2003, Pages 974-981

  Ott, Vanessa L ^a   Cambier, John C ^a   Kappler, John ^a,b   Marrack, Philippa ^a,b   Swanson, Bradley J ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; LEUKOTRIENE B4;

ANIMAL CELL; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; INFLAMMATORY INFILTRATE; LEUKOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MALE; MAST CELL; MEMORY CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; CHEMOTAXIS, LEUKOCYTE; FEMALE; LEUKOTRIENE B4; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CCR5; RECEPTORS, INTERLEUKIN-2; RECEPTORS, LEUKOTRIENE B4; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 0142061071     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni971     Document Type: Article

References (43)

1. Metcalfe, D.D., Baram, D. & Mekori, Y.A. Mast cells. Physiol. Rev. 77, 1033-1079 (1997).
2. Benoist, C. & Mathis, D. Mast cells in autoimmune disease. Nature 420, 875-878 (2002).
3. Mekori, Y.A. & Metcalfe, D.D. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104, 517-523 (1999).
4. Gonzalez, M.C. et al. Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in late-phase responders. Am. Rev. Respir. Dis. 136, 600-604 (1987).
5. Haczku, A. et al. T-cells subsets and activation in bronchial mucosa of sensitized Brown-Norway rats after single allergen exposure. Immunology 85, 591-597 (1995).
6. + T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J. Exp. Med. 183, 1719-1729 (1996).
7. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
8. Masopust, D., Vezys, V., Marzo, A.L. & Lefrancois, L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417 (2001).
9. + T cells. J. Exp. Med. 194, 953-966 (2001).
10. Manjunath, N. et al. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108, 871-878 (2001).
11. dok, is a mediator of FcγIIB inhibition of FcERI signaling. J. Immunol. 168, 4430-4439 (2002).
12. Teague, T.K. et al. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. USA 96, 12691-12696 (1999).
13. Yokomizo, T., Izumi, T. & Shimizu, T. Leukotriene B4: metabolism and signal transduction. Arch. Biochem. Biophys. 385, 231-241 (2001).
14. Dixon, R.A. et al. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343, 282-284 (1990).
15. 4-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis. J. Exp. Med. 192, 439-446 (2000).
16. 4, but not formylmethionyl leucylphenylalanine, stimulate CD18-independent migration of neutrophils across human pulmonary endothelial cells in vitro. Am. J. Respir. Cell. Mol. Biol. 23, 154-161 (2000).
17. 4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192, 421-432 (2000).
18. Koch, K. et al. (+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model. J. Med. Chem. 37, 3197-3199 (1994).
19. Showell, H.J., Breslow, R., Conklyn, M.J., Hingorani, G.P. & Koch, K. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro. Br. J. Pharmacol. 117, 1127-1132 (1996).
20. Yokomizo, T., Kato, K., Hagiya, H., Izumi, T. & Shimizu, T. Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J. Biol. Chem. 276, 12454-12459 (2001).
21. Yokomizo, T. et al. Leukotriene B4 receptor. Cloning and intracellular signaling. Am. J. Respir. Crit. Care Med. 161, S51-55 (2000).
22. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y. & Shimizu, T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620-624 (1997).
23. Wherry, E.J. et al. Lineage relationship and protective immunity of memory CDB T cell subsets. Nat. Immunol. 4, 225-234 (2003).
24. Freeland, H.S., Schleimer, R.P., Schulman, E.S., Lichtenstein, L.M. & Peters, S.P. Generation of leukotriene B4 by human lung fragments and purified human lung mast cells. Am. Rev. Respir. Dis. 138, 389-394 (1988).
25. Katz, H.R. et al. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. J. Immunol. 148, 868-871 (1992).
26. Sayama, K. et al. Transcriptional response of human mast cells stimulated via the FcERI and identification of mast cells as a source of IL-11. BMC Immunol. 3, 5 (2002).
27. Nakajima, T. et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following FcE receptor I cross-linking: an interspecies comparison. Blood 100, 3861-3868 (2002).
28. Aoki, M., Pawankar, R., Niimi, Y. & Kawana, S. Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES. Int. Arch. Allergy Immunol. 130, 216-223 (2003).
29. Kimura, Y., Pawankar, R., Aoki, M., Niimi, Y. & Kawana, S. Mast cells and T cells in Kimura's disease express increased levels of interleukin-4, interleukin-5, eotaxin and RANTES. Clin. Exp. Allergy 32, 1787-1793 (2002).
30. Leppert, D. et al. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. Faseb J. 9, 1473-1481 (1995).
31. 4 receptor antagonist in vitro. Biochem. Biophys. Res. Commun. 264, 321-326 (1999).
32. Gualde, N., Atluru, D. & Goodwin, J.S. Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets. J. Immunol. 134, 1125-1129 (1985).
33. Payan, D.G., Missirian-Bastian, A. & Goetzl, E.J. Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. Proc. Natl. Acad. Sci. USA 81, 3501-3505 (1984).
34. Bailie, M.B. et al. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157, 5221-5224 (1996).
35. Griffiths, R.J. et al. Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice. J. Exp. Med. 185, 1123-1129 (1997).
36. Turner, C.R. et al. In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma. J. Clin. Invest. 97, 381-387 (1996).
37. Henderson, W.R., Jr. et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184, 1483-1494 (1996).
38. Malaviya, R. & Abraham, S.N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol. 67, 841-846 (2000).
39. Ramos, B.F., Zhang, Y., Qureshi, R. & Jakschik, B.A. Mast cells are critical for the production of leukotrienes responsible for neutrophil recruitment in immune complex-induced peritonitis in mice. J. Immunol. 147, 1636-1641 (1991).
40. Iwamoto, I., Tomoe, S., Tomioka, H. & Yoshida, S. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration. J. Immunol. 151, 2116-2123 (1993).
41. Lefrancois, L. & Masopust, D. T cell immunity in lymphoid and non-lymphoid tissues. Curr. Opin. Immunol. 14, 503-508 (2002).
42. Swanson, B.J., Murakami, M., Mitchell, T.C., Kappler, J. & Marrack, P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 17, 605-615 (2002).
43. Oshiba, A. et al. Passive transfer of immediate hypersensitivity and airway hyperreponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J. Clin. Invest. 97, 1398-1408 (1996).